The GO SAVE Study is a Clinical Research study testing a medication called Golimumab. Although already approved for the treatment of moderate to severe RA, the GO SAVE study is designed to further examine the effectiveness of Golimumab in reducing pain and maintain movement in joints in patients with RA.
You may be eligible to participate if you;
- Are 18 years or older
- Have received at least 3 months of treatment with one of the TNF-alpha blocking agents etanercept or adalimumab, in combination with methotrexate.
- Are no getting adequate control of your symptoms
Other study requirements ill also need to be met for you to be able to participate in the GO SAVE study. These requirements will be reviewed if you decide to contact the study site.
Please contact our Research Department to inquire about this study.